Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial
Related Posts
Poterucha TJ, Jing L, Ricart RP, Adjei-Mosi M, Finer J, Hartzel D, Kelsey C, Long A, Rocha D, Ruhl JA, vanMaanen D, Probst MA, Daniels[...]
Turcu AF, Freeman MW, Bancos I, Ben-Shlomo A, Hamidi O, Hamrahian AH, Huang W, Kirschner LS, Sam R, Mallappa A, Tuyishimire B, Lihn AS, Perl[...]
Hein Da Rosa T, Ramsey SH, Lee JJ, Kozlova NY, Zhao Z, Kim J, Schneider AC, Li S, Katiki M, Firestein GS, Murali R, Santelli[...]